EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The roles of anti-Müllerian hormone in breast cancer

Xuan Chen, Sixuan Liu, Xue Peng, Xiangyun Zong iD

Endocrine-Related Cancer · 06.07.2023 · 30 (10)

DOI: 10.1530/erc-23-0060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, erschienen am 06.07.2023. Verfasst von Xuan Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Anti-Mullerian Hormone, Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-Müllerian hormone (AMH) is produced and secreted by granulosa cells of growing follicles, and its main role is to inhibit the recruitment of primordial follicles, reduce the sensitivity of follicles to follicle-stimulating hormone (FSH), and regulate FSH-dependent preantral follicle growth. It has become an effective indicator of ovarian reserve in clinical practice. Research on AMH and its receptors in recent years has led to a better understanding of its role in breast cancer. AMH specifically binds to anti-Müllerian hormone receptor II (AMHRII) to activate downstream pathways and regulate gene transcription. Since AMHRII is expressed in breast cancer cells and triggers apoptosis, AMH/AMHRII may play an important role in the occurrence, treatment, and prognosis of breast cancer, which needs further research. The AMH level is a potent predictor of ovarian function after chemotherapy in premenopausal breast cancer patients older than 35 years, either for ovarian function injury or ovarian function recovery. Moreover, AMHRII has the potential to be a new marker for the molecular typing of breast cancer and a new target for breast cancer treatment, which may be a link in the downstream pathway after TP53 mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Mullerian HormoneBreast NeoplasmsFemaleHumansOvarian FollicleGranulosa CellsFollicle Stimulating Hormone

Stichwörter der Autor:innen

anti-Müllerian hormoneanti-Müllerian hormone receptor IIbreast cancerhypothalamic–pituitary–ovarian axisovarian function

Substanzen

Anti-Mullerian HormoneFollicle Stimulating Hormone

Autor:innen und Institutionen

  • Department of Breast Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Xiangyun Zong

Zitieren

APA

Chen, X., Liu, S., Peng, X., & Zong, X. (2023). The roles of anti-Müllerian hormone in breast cancer. Endocrine-Related Cancer, 30(10). https://doi.org/10.1530/erc-23-0060

Vancouver

Chen X, Liu S, Peng X, Zong X. The roles of anti-Müllerian hormone in breast cancer. Endocrine-Related Cancer. 2023;30(10). doi:10.1530/erc-23-0060

BibTeX
@article{Chen2023,
  author = {Chen, Xuan and Liu, Sixuan and Peng, Xue and Zong, Xiangyun},
  title = {The roles of anti-Müllerian hormone in breast cancer},
  journal = {Endocrine-Related Cancer},
  year = {2023},
  volume = {30},
  number = {10},
  doi = {10.1530/erc-23-0060}
}
Kostenlos starten →